Matches in SemOpenAlex for { <https://semopenalex.org/work/W4327719902> ?p ?o ?g. }
- W4327719902 endingPage "122866" @default.
- W4327719902 startingPage "122866" @default.
- W4327719902 abstract "Breast cancer is the most commonly diagnosed type of cancer among the female population worldwide. It is a disease with a high incidence and geographic distribution that negatively impacts global public health and deleteriously affect the quality of life of cancer patients. Among the new approaches, cancer immunotherapy is the most promising trend in oncology by stimulating the host's own immune system to efficiently destroy cancer cells. Recent evidence has indicated that iron oxide nanoparticles can promote the reprograming of M2 into M1 macrophages with anti-tumor effects in the tumor microenvironment. Thus, the aim of the present work was to evaluate the ability of polyaniline-coated maghemite (Pani/γ-Fe2O3) nanoparticles to modulate human macrophages in 2D monolayers and 3D multicellular breast cancer models. It was observed that Pani/γ-Fe2O3 NPs re-educated IL-10-stimulated macrophages towards a pro-inflammatory profile, decreasing the proportion of CD163+ and increasing the CD86+ proportion in 2D models. NPs were successfully taken-up by macrophages presented in the 3D model and were also able to induce an increasing in their CD86+ proportion in triple MCTs model. Overall, our findings open new perspectives on the use of Pani/γ-Fe2O3 NPs as an immunomodulatory therapy for macrophage reprogramming towards an anti-tumor M1 phenotype, providing a new tool for breast cancer immunotherapies." @default.
- W4327719902 created "2023-03-18" @default.
- W4327719902 creator A5001646389 @default.
- W4327719902 creator A5012972465 @default.
- W4327719902 creator A5021742562 @default.
- W4327719902 creator A5027808353 @default.
- W4327719902 creator A5039885223 @default.
- W4327719902 creator A5041458969 @default.
- W4327719902 creator A5048451016 @default.
- W4327719902 creator A5064867958 @default.
- W4327719902 creator A5073490924 @default.
- W4327719902 date "2023-04-01" @default.
- W4327719902 modified "2023-10-18" @default.
- W4327719902 title "Reprogramming of tumor-associated macrophages by polyaniline-coated iron oxide nanoparticles applied to treatment of breast cancer" @default.
- W4327719902 cites W1521009884 @default.
- W4327719902 cites W1971661335 @default.
- W4327719902 cites W1977556024 @default.
- W4327719902 cites W1992257191 @default.
- W4327719902 cites W2002689758 @default.
- W4327719902 cites W2008971642 @default.
- W4327719902 cites W2013899855 @default.
- W4327719902 cites W2017335731 @default.
- W4327719902 cites W2019733225 @default.
- W4327719902 cites W2026903616 @default.
- W4327719902 cites W2049999948 @default.
- W4327719902 cites W2061123122 @default.
- W4327719902 cites W2093705034 @default.
- W4327719902 cites W2122778942 @default.
- W4327719902 cites W2123672726 @default.
- W4327719902 cites W2129883523 @default.
- W4327719902 cites W2136428555 @default.
- W4327719902 cites W2146341111 @default.
- W4327719902 cites W2157255155 @default.
- W4327719902 cites W2162639406 @default.
- W4327719902 cites W2236643502 @default.
- W4327719902 cites W2277313374 @default.
- W4327719902 cites W2427645657 @default.
- W4327719902 cites W2526973451 @default.
- W4327719902 cites W2556053883 @default.
- W4327719902 cites W2582686270 @default.
- W4327719902 cites W2612323044 @default.
- W4327719902 cites W2615301036 @default.
- W4327719902 cites W2735818385 @default.
- W4327719902 cites W2740653964 @default.
- W4327719902 cites W2744067212 @default.
- W4327719902 cites W2755641375 @default.
- W4327719902 cites W2766738495 @default.
- W4327719902 cites W2767749438 @default.
- W4327719902 cites W2781438702 @default.
- W4327719902 cites W2789230893 @default.
- W4327719902 cites W2790909830 @default.
- W4327719902 cites W2902852740 @default.
- W4327719902 cites W2905494922 @default.
- W4327719902 cites W2910083100 @default.
- W4327719902 cites W2916814431 @default.
- W4327719902 cites W2933335062 @default.
- W4327719902 cites W2937061963 @default.
- W4327719902 cites W2952869085 @default.
- W4327719902 cites W2971866769 @default.
- W4327719902 cites W2982950106 @default.
- W4327719902 cites W2991203943 @default.
- W4327719902 cites W3003483326 @default.
- W4327719902 cites W3014992842 @default.
- W4327719902 cites W3031081333 @default.
- W4327719902 cites W3037095003 @default.
- W4327719902 cites W3050950703 @default.
- W4327719902 cites W3088462877 @default.
- W4327719902 cites W3128318804 @default.
- W4327719902 cites W3134164720 @default.
- W4327719902 cites W3155924509 @default.
- W4327719902 cites W3187648048 @default.
- W4327719902 cites W3208805449 @default.
- W4327719902 cites W3215418794 @default.
- W4327719902 cites W4213245349 @default.
- W4327719902 cites W4245662629 @default.
- W4327719902 cites W4281786101 @default.
- W4327719902 cites W4285155654 @default.
- W4327719902 doi "https://doi.org/10.1016/j.ijpharm.2023.122866" @default.
- W4327719902 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36934882" @default.
- W4327719902 hasPublicationYear "2023" @default.
- W4327719902 type Work @default.
- W4327719902 citedByCount "3" @default.
- W4327719902 countsByYear W43277199022023 @default.
- W4327719902 crossrefType "journal-article" @default.
- W4327719902 hasAuthorship W4327719902A5001646389 @default.
- W4327719902 hasAuthorship W4327719902A5012972465 @default.
- W4327719902 hasAuthorship W4327719902A5021742562 @default.
- W4327719902 hasAuthorship W4327719902A5027808353 @default.
- W4327719902 hasAuthorship W4327719902A5039885223 @default.
- W4327719902 hasAuthorship W4327719902A5041458969 @default.
- W4327719902 hasAuthorship W4327719902A5048451016 @default.
- W4327719902 hasAuthorship W4327719902A5064867958 @default.
- W4327719902 hasAuthorship W4327719902A5073490924 @default.
- W4327719902 hasBestOaLocation W43277199021 @default.
- W4327719902 hasConcept C121608353 @default.
- W4327719902 hasConcept C126322002 @default.
- W4327719902 hasConcept C1491633281 @default.
- W4327719902 hasConcept C185592680 @default.